These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 12545304)

  • 61. Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.
    Khan SQ; Dhillon O; Kelly D; Squire IB; Struck J; Quinn P; Morgenthaler NG; Bergmann A; Davies JE; Ng LL
    J Am Coll Cardiol; 2008 May; 51(19):1857-64. PubMed ID: 18466800
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Development of a novel, N-terminal-proBNP (NT-proBNP) assay with a low detection limit.
    Karl J; Borgya A; Gallusser A; Huber E; Krueger K; Rollinger W; Schenk J
    Scand J Clin Lab Invest Suppl; 1999; 230():177-81. PubMed ID: 10389216
    [TBL] [Abstract][Full Text] [Related]  

  • 63. N-terminal pro-brain natriuretic peptide levels in patients with non-ST-elevation myocardial infarction.
    Zeller M; Cottin Y; Laurent Y; Danchin N; L'Huillier I; Collin B; Desgrés J; Ravisy J; Janin-Manificat L; Makki H; Jolak M; Beer JC; Dentan G; Gambert P; Wolf JE
    Cardiology; 2004; 102(1):37-40. PubMed ID: 14988617
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Reperfusion before percutaneous coronary intervention in ST-elevation myocardial infarction patients is associated with lower N-terminal pro-brain natriuretic peptide levels during follow-up, irrespective of pre-treatment with full-dose fibrinolysis.
    Sinnaeve PR; Ezekowitz JA; Bogaerts K; Droogne W; Jarai R; Huber K; Granger CB; Desmet WJ; Armstrong PW; Van de Werf FJ;
    Eur Heart J; 2009 Sep; 30(18):2213-9. PubMed ID: 19586960
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [The efficacy of percutaneous coronary intervention combined percutaneous thrombectomy on coronary thrombotic lesions in patients with acute myocardial infarction].
    Yang SS; Li WM; Zhou LJ; Li Y; Wang LF; Han W; Chen YD; Zhou HY; Pan W
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Dec; 35(12):1136-40. PubMed ID: 18341818
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Serum N-terminal pro-B-type natriuretic peptide levels at the time of hospital admission predict of microvascular obstructions after primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.
    Kim MK; Chung WY; Cho YS; Choi SI; Chae IH; Choi DJ; Park YB
    J Interv Cardiol; 2011 Feb; 24(1):34-41. PubMed ID: 21198848
    [TBL] [Abstract][Full Text] [Related]  

  • 67. N-terminal pro-brain natriuretic peptide after myocardial infarction: a marker of cardio-renal function.
    Luchner A; Hengstenberg C; Löwel H; Trawinski J; Baumann M; Riegger GA; Schunkert H; Holmer S
    Hypertension; 2002 Jan; 39(1):99-104. PubMed ID: 11799086
    [TBL] [Abstract][Full Text] [Related]  

  • 68. NT-proBNP in unstable coronary artery disease--experiences from the FAST, GUSTO IV and FRISC II trials.
    Jernberg T; James S; Lindahl B; Stridsberg M; Venge P; Wallentin L
    Eur J Heart Fail; 2004 Mar; 6(3):319-25. PubMed ID: 14987583
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The relationship between early recanalization and serum NT-proBNP levels in patients with a first ST-segment elevation myocardial infarction treated with primary coronary angioplasty.
    Szadkowska I; Goch JH; Polak L; Stepień H; Chizyński K
    Acta Cardiol; 2007 Oct; 62(5):479-84. PubMed ID: 17982969
    [TBL] [Abstract][Full Text] [Related]  

  • 70. N-terminal pro-brain natriuretic peptide is a biomarker of congestive heart failure and predictive of 30-day untoward clinical outcomes in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
    Wu CJ; Chang HW; Hung WC; Yang CH; Chen YH; Su CY; Yip HK
    Circ J; 2006 Feb; 70(2):163-8. PubMed ID: 16434809
    [TBL] [Abstract][Full Text] [Related]  

  • 71. In-hospital and long-term outcomes of patients with acute myocardial infarction undergoing direct angioplasty during regular and after hours.
    Beohar N; Chandwaney R; Goodreau LM; Davidson CJ
    J Invasive Cardiol; 2001 Oct; 13(10):669-72. PubMed ID: 11581506
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prognostic Significance of NT-proBNP Levels in Patients over 65 Presenting Acute Myocardial Infarction Treated Invasively or Conservatively.
    Drewniak W; Szybka W; Bielecki D; Malinowski M; Kotlarska J; Krol-Jaskulska A; Popielarz-Grygalewicz A; Konwicka A; Dąbrowski M
    Biomed Res Int; 2015; 2015():782026. PubMed ID: 26539524
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Intracoronary infusion of bone marrow-derived mononuclear cells abrogates adverse left ventricular remodelling post-acute myocardial infarction: insights from the reinfusion of enriched progenitor cells and infarct remodelling in acute myocardial infarction (REPAIR-AMI) trial.
    Schächinger V; Assmus B; Erbs S; Elsässer A; Haberbosch W; Hambrecht R; Yu J; Corti R; Mathey DG; Hamm CW; Tonn T; Dimmeler S; Zeiher AM;
    Eur J Heart Fail; 2009 Oct; 11(10):973-9. PubMed ID: 19789401
    [TBL] [Abstract][Full Text] [Related]  

  • 74. N-terminal pro-brain natriuretic peptide and the timing, extent and mortality in ST elevation myocardial infarction.
    Ezekowitz JA; Théroux P; Chang W; Mahaffey KW; Granger CB; Weaver WD; Hochman JS; Armstrong PW
    Can J Cardiol; 2006 Apr; 22(5):393-7. PubMed ID: 16639474
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A prognostic model for short term adverse events in normotensive patients with pulmonary embolism.
    Agterof MJ; Schutgens RE; Moumli N; Eijkemans MJ; van der Griend R; Tromp EA; Biesma DH
    Am J Hematol; 2011 Aug; 86(8):646-9. PubMed ID: 21630313
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Release kinetics of N-terminal pro-B-type natriuretic peptide in a clinical model of acute myocardial infarction.
    Liebetrau C; Gaede L; Dörr O; Troidl C; Voss S; Hoffmann J; Paszko A; Weber M; Rolf A; Hamm C; Nef H; Möllmann H
    Clin Chim Acta; 2014 Feb; 429():34-7. PubMed ID: 24291058
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Systemic and cardiac catecholamines during elective PTCA and during immediate PTCA for acute myocardial infarction.
    Richardt G; Münch G; Neumann FJ; Rauch B; Kurz T
    Basic Res Cardiol; 1997 Feb; 92(1):52-60. PubMed ID: 9062652
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Risk stratification after acute myocardial infarction in the reperfusion era.
    Michaels AD; Goldschlager N
    Prog Cardiovasc Dis; 2000; 42(4):273-309. PubMed ID: 10661780
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Left ventricular remodeling in the first year after acute myocardial infarction and the predictive value of N-terminal pro brain natriuretic peptide.
    Nilsson JC; Groenning BA; Nielsen G; Fritz-Hansen T; Trawinski J; Hildebrandt PR; Jensen GB; Larsson HB; Sondergaard L
    Am Heart J; 2002 Apr; 143(4):696-702. PubMed ID: 11923808
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prognostic value of biological markers in myocardial infarction patients.
    Berezin AE; Samura TA
    Asian Cardiovasc Thorac Ann; 2013 Apr; 21(2):142-50. PubMed ID: 24532611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.